Dr. Mukesh Kumar Sharma, MD

Dr. Sharma practices at DaVita Reno Dialysis Center in Reno, Nevada.

Dr. Sharma's NPI, 1871704122, was assigned on May 25, 2007. Dr. Sharma graduated from Government Medical College Amritsar in 2001. Dr. Sharma holds Nevada license 19222.

Dr. Sharma's primary practice is DaVita Reno Dialysis Center, at 1500 E Second Street Suite 101, Reno, NV 89502 in Washoe County. The practice phone is (775) 329-2100.

Dr. Sharma's primary practice is DaVita Reno Dialysis Center in Reno, Nevada. Dr. Sharma is also affiliated with Renown Regional Medical Center. The medical group on file is Sierra Nevada Specialty Care. Dmand AI also links Dr. Sharma to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sharma practices, 7 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Sharma's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Sharma is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sharma's licenses on file in 4 states: Nevada, Texas, Arkansas and Louisiana.

Dmand AI lists acute kidney failure and chronic kidney disease among the conditions Dr. Sharma treats.

CMS data shows 1,362 Medicare services from Dr. Sharma across 18 procedure codes in 2024, for 365 Medicare patients. Medicare paid $172,584 for them.

CMS counts 365 Medicare patients who saw Dr. Sharma in 2024. The largest group is under 65, with 117 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 34% are also on Medicaid. Their average risk score is 6.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sharma's median patient age at 66, with 41% women.

In 2024, Dr. Sharma wrote 162 Medicare Part D claims for 47 patients. 91% of them were for generic drugs. CMS names the drug for 33 of them, across 2 drugs with 11 or more claims each, at $1,132 in total drug cost. In 2022, CMS named 56 claims across 4 drugs.

Dr. Sharma accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sharma as offering telehealth.

Dmand AI links 68 papers to Dr. Sharma, published from 2012 to 2025. 2022 was the busiest year, with 7. The most frequent topics are DNA-Binding Proteins, Biosensing Techniques and Cell Line, Tumor. Dr. Sharma has published most often in Indian J Plast Surg. Dr. Sharma's most frequent co-authors are Tushar Jitendra Vachharajani, MD, Adrian Paul Abreo, MD and Ankur Gupta, MD, PhD.

Dmand AI links Dr. Sharma to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Headache, Migraine Disorders and Pain. Eli Lilly and Company sponsors the most, 3.

CMS Open Payments shows 65 general payments to Dr. Sharma from 22 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 51% of the total. Relypsa, Inc. paid the most, $14,833.

Dr. Sharma graduated from Government Medical College Amritsar in 2001.

Dr. Sharma is in network with 18 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.